The China Cancer Screening Trial Feasibility Study
نویسندگان
چکیده
منابع مشابه
Screening Trial for Breast Cancer in China
Breast cancer is by far the most common female cancer (21.6/100,000) and one of the primary causes of death (5.7/100,000) among Chinese women, with an estimated 169,452 new cases and 44,908 deaths in 2008 1. The total annual number of new cases in regions with limited health resources continues to increase 1,2. The causes of breast cancer remain unclear. Early detection is believed to be the be...
متن کاملSQUID Magnetometry for Cancer Screening a Feasibility Study
The recent demonstration that nanoparticles associated with various biological molecules and pharmacological agents can be administered systemically to humans, without toxicity from the particles, has opened a new era in the targeting of such particles to specific tissues in the body for the imaging and therapy of disease. The majority of particles used for this purpose contain iron and are det...
متن کاملLung cancer screening feasibility in Australia.
Hospital King’s Lynn NHS Foundation Trust, King’s Lynn, UK. James Paget University Hospitals NHS Foundation Trust, Great Yarmouth, UK. Peterborough and Stamford Hospitals NHS Foundation Trust, Peterborough, UK. West Suffolk Hospitals NHS Foundation Trust, Bury St Edmunds, UK. Mid Essex Hospital Services NHS Trust, Chelmsford, UK. MRC Biostatistics Unit, Institute of Public Health, University of...
متن کاملFeasibility of conducting a randomized control trial for liver cancer screening: is a randomized controlled trial for liver cancer screening feasible or still needed?
UNLABELLED Screening for hepatocellular carcinoma (HCC) is commonly practiced and recommended in published guidelines, but evidence for its efficacy has been controversial. We tested the feasibility of conducting a randomized controlled trial (RCT) of HCC surveillance in patients with cirrhosis and followed up those offered screening to detect clinical outcomes. Participation was offered to pat...
متن کاملThe PROFILE Feasibility Study: Targeted Screening of Men With a Family History of Prostate Cancer
BACKGROUND A better assessment of individualized prostate cancer (PrCa) risk is needed to improve screening. The use of the prostate-specific antigen (PSA) level for screening in the general population has limitations and is not currently advocated. Approximately 100 common single nucleotide polymorphisms (SNPs) have been identified that are associated with the risk of developing PrCa. The PROF...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: The Lancet
سال: 2015
ISSN: 0140-6736
DOI: 10.1016/s0140-6736(15)00616-9